Koyfin Home > Directory > Health Care > Amedisys Inc > EBITDA / Interest Expenses

Amedisys Inc EBITDA / Interest Expenses Chart (AMED)

Amedisys Inc annual/quarterly EBITDA / Interest Expenses from 2010 to 2020. EBITDA / Interest is the interest coverage ratio and measures the ability of a company to service its debt.
  • Amedisys Inc EBITDA / Interest Expenses for the quarter ending June 06, 2020 was $22m a 27.31% increase of 6m year over year
  • Amedisys Inc EBITDA / Interest Expenses for the last 12 months ending June 06, 2020 was $19m a 7.32% increase of 1m year over year
  • Amedisys Inc Annual EBITDA / Interest Expenses for 2019 was $16m a -41.04% decrease of -7m from 2018
  • Amedisys Inc Annual EBITDA / Interest Expenses for 2018 was $23m a -11.59% decrease of -3m from 2017
  • Amedisys Inc Annual EBITDA / Interest Expenses for 2017 was $25m a 38.14% increase of 10m from 2016
Other Ratios Metrics:
  • Amedisys Inc Total Debt / Capital for the quarter ending December 12, 2018 was $2m a -799.46% decrease of -12m year over year
  • Amedisys Inc Other Liabilities for the quarter ending December 12, 2018 was $6m a 1.54% increase of 0m year over year
  • Amedisys Inc Total Debt / Equity for the quarter ending December 12, 2018 was $2m a -924.84% decrease of -14m year over year
View Chart On Koyfin

Quarterly AMED EBITDA / Interest Expenses Data

06/2020$22m
03/2020$18m
12/2019$19m
09/2019$16m
06/2019$14m
03/2019$17m
12/2018$26m
09/2018$22m
06/2018$21m
03/2018$23m

Annual AMED EBITDA / Interest Expenses Data

2019$16m
2018$23m
2017$25m
2016$16m
2015$8m
2014$8m
2013$10m
2012$8m
2011$17m
2010$28m